Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report) saw a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 68,600 shares, a growth of 25.4% from the February 28th total of 54,700 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 94,300 shares, the short-interest ratio is presently 0.7 days.
Sandoz Group Stock Performance
Shares of SDZNY stock opened at $41.00 on Wednesday. The firm has a fifty day simple moving average of $45.27 and a 200-day simple moving average of $43.87. Sandoz Group has a twelve month low of $27.79 and a twelve month high of $49.81.
Analyst Upgrades and Downgrades
Separately, UBS Group downgraded Sandoz Group from a “strong-buy” rating to a “hold” rating in a report on Monday, February 3rd.
Sandoz Group Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Featured Stories
- Five stocks we like better than Sandoz Group
- Health Care Stocks Explained: Why You Might Want to Invest
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- Are Penny Stocks a Good Fit for Your Portfolio?
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- 10 Best Airline Stocks to Buy
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
